Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82009-115

4 FDA label images from Quallent Pharmaceuticals Health Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82009-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure1 (Structure1)

Structure1 (Structure1)
Chemical structure diagram of Metoprolol succinate showing two parts: the Metoprolol moiety including a phenyl ring with attached groups, and the succinate moiety with carboxyl groups. The structure represents the extended release salt form.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). The chart compares metoprolol succinate extended-release tablets versus placebo across various subgroups such as geographic region, NYHA class, ejection fraction, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension status, and heart rate. Each subgroup's risk estimate is plotted with confidence intervals, indicating which treatment is favored.*
FDA Label Image

Container100mg1 (Container100mg1)

Container100mg1 (Container100mg1)
Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg, film-coated oral tablets. The package contains 500 tablets. Manufactured by Dr. Reddy's Laboratories Limited, India, and labeled for Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. Includes storage instructions, warning to keep out of reach of children, and dosage reference to package insert. Features barcode and Quallent logo.*
FDA Label Image

Container200mg1 (Container200mg1)

Container200mg1 (Container200mg1)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 200 mg strength, film-coated tablets. The label indicates a package size of 500 tablets and includes storage instructions, a warning to keep out of children's reach, and manufacturing details by Dr. Reddy's Laboratories Limited and Quallent Pharmaceuticals Health LLC. The label also features a barcode and the Quallent Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.